Global medical companies are showcasing hundreds of innovative technologies at the ongoing China International Import Expo (CIIE), reflecting the growing significance of the Chinese market in the global healthcare industry.
Industry leaders have expressed strong confidence in China’s evolving healthcare sector. According to Huzur Devletsah, President of Lilly China, China represents a vital and strategic market for the company. He highlighted that supportive national policies and the establishment of new pilot zones in major cities are fostering growth and innovation.
Rick Kozloski, President of Alcon China, emphasized the company’s commitment to delivering timely innovations and improving accessibility for patients across the Chinese mainland. He noted that Alcon is dedicated to meeting the growing needs of China’s healthcare system.
Jenny Zheng, General Manager for Greater China at Illumina, highlighted China’s rapid scientific advancements. She affirmed the company’s “for China, in China” commitment and stated that the CIIE serves as a crucial platform for global collaboration and exchange.
The active participation of these global medical firms at the CIIE underscores the dynamic role China plays in the global healthcare landscape. As China continues to open its markets and encourage innovation, international companies are eager to contribute to and benefit from this growth.
Reference(s):
cgtn.com
